Cardiovascular regulation profile predicts developmental trajectory of BMI and pediatric obesity

Paulo A Graziano1, Susan D Calkins, Susan P Keane

  • 1Department of Psychology, Center for Children and Families, Florida International University, Miami, Florida, USA. pgrazian@fiu.edu

Insights

Poor cardiovascular regulation in early childhood, specifically low respiratory sinus arrhythmia (RSA) suppression, predicts pediatric obesity risk, particularly in African-American children. This highlights autonomic nervous system function as a key factor in childhood weight development.

Area of Science:

  • Pediatric Health
  • Cardiovascular Physiology
  • Autonomic Nervous System Function

Background:

  • Pediatric obesity is a growing public health concern with complex developmental origins.
  • Cardiovascular regulation, reflecting autonomic nervous system (ANS) activity, plays a role in physiological development.
  • Early life physiological markers may predict later health outcomes, including obesity.

Purpose of the Study:

  • To investigate the predictive role of early childhood cardiovascular regulation in the development of pediatric obesity.
  • To examine the association between respiratory sinus arrhythmia (RSA) and heart period (HP) changes at age 5.5 and body mass index (BMI) trajectories up to age 10.5.
  • To explore potential moderating effects of racial status on this association.

Main Methods:

  • Longitudinal study of 268 children, assessing cardiovascular regulation (RSA and HP changes) at age 5.5.
  • Measured height and weight at ages 5.5, 7.5, and 10.5 to calculate BMI and track growth.
  • Statistical analyses examined the relationship between early cardiovascular regulation profiles and later BMI development, including interaction with race.

Main Results:

  • Lower levels of RSA suppression and HP change at age 5.5 predicted greater BMI growth and increased risk of overweight/obesity at age 10.5.
  • This association was significant specifically for African-American children, indicating a racial interaction.
  • An autonomic profile with low parasympathetic activity emerged as a risk factor for pediatric obesity in this subgroup.

Conclusions:

  • Early-life autonomic cardiovascular regulation, particularly parasympathetic activity, is a significant predictor of pediatric obesity risk.
  • The findings underscore the importance of considering racial disparities in understanding the link between physiological regulation and obesity development.
  • Interventions targeting autonomic regulation may be beneficial for preventing pediatric obesity in at-risk populations.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...